Cases 41 - 50 of 5,522
S.W. et al v. Johnson & Johnson et al
as 2:2022cv00475
Plaintiff:
S. W. and J. W.
Defendant:
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
J. A. H. et al v. Johnson & Johnson et al
as 2:2022cv00472
Plaintiff:
J. A. H. and J. S., IV
Defendant:
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
K.A.D. et al v. Johnson & Johnson et al
as 2:2022cv00476
Plaintiff:
K. A. D. and B. D. G.
Defendant:
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
Zaifert v. Avanir Pharmaceuticals, Inc.
as 2:2022cv03547
Plaintiff:
Matthew Zaifert
Defendant:
Avanir Pharmaceuticals, Inc.
Cause Of Action: 28 U.S.C. § 1332 Diversity-Other Contract
Gray v. Aurobindo Pharma Ltd. et al
as 1:2022cv02353
Plaintiff:
Louise Gray
Defendant:
Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Sciegen Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1446 Notice of Removal
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00089
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00085
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv00063
Plaintiff:
Bayer Pharma AG,, Bayer AG, and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2022cv00061
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Burlington Drug Company, Inc. et al v. Merck & Company, Inc. et al
as 2:2022cv00269
Plaintiff:
Burlington Drug Company, Inc., Dakota Drug, Inc., J M Smith Corporation doing business as Smith Drug Company and others
Defendant:
Merck & Company, Inc., Merck Sharp & Dohme Corporation, Schering-Plough Corporation and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
